Chronic Fatigue Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome; Myalgic Encephalomyelitis Interventions: Drug: NAC 900mg/day; Drug: NAC 3600mg/day; Drug: NAC 0mg/day (Placebo) Sponsors: Weill Medical College of Cornell University; National Institute of Neurological Disorders and Stroke (NINDS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2020 Category: Research Source Type: clinical trials